lerapolturev (PVS-RIPO) / Istari Oncology 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 


«123
  • ||||||||||  lerapolturev (PVS-RIPO) / Istari Oncology
    Enrollment change, Trial primary completion date:  PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) -  Nov 15, 2015   
    P1,  N=65, Recruiting, 
    N=32 --> 65 | Trial primary completion date: Jan 2016 --> Jan 2017
  • ||||||||||  lerapolturev (PVS-RIPO) / Istari Oncology
    Trial primary completion date:  PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) -  Jan 18, 2015   
    P1,  N=32, Recruiting, 
    N=32 --> 65 | Trial primary completion date: Jan 2016 --> Jan 2017 Trial primary completion date: Jan 2015 --> Jan 2016
  • ||||||||||  lerapolturev (PVS-RIPO) / Istari Oncology
    Enrollment change:  PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) -  Aug 22, 2014   
    P1,  N=32, Recruiting, 
    Trial primary completion date: Jan 2015 --> Jan 2016 N=18 --> 32
  • ||||||||||  lerapolturev (PVS-RIPO) / Istari Oncology
    Enrollment open:  PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) -  Aug 28, 2013   
    P1,  N=18, Recruiting, 
    N=18 --> 32 Suspended --> Recruiting
  • ||||||||||  lerapolturev (PVS-RIPO) / Istari Oncology
    New P1 trial:  PVSRIPO for Recurrent Glioblastoma (GBM) (clinicaltrials.gov) -  Dec 12, 2011   
    P1,  N=18, Recruiting,